tradingkey.logo

Ekso Bionics Holdings Inc

EKSO

3.290USD

-0.200-5.73%
Close 08/04, 16:00ETQuotes delayed by 15 min
8.57MMarket Cap
LossP/E TTM

Ekso Bionics Holdings Inc

3.290

-0.200-5.73%
More Details of Ekso Bionics Holdings Inc Company
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
Company Info
Ticker SymbolEKSO
Company nameEkso Bionics Holdings Inc
IPO dateApr 10, 2013
CEOMr. Scott G. Davis
Number of employees61
Security typeOrdinary Share
Fiscal year-endApr 10
Address101 Glacier Point
CitySAN RAFAEL
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code94901
Phone15109841761
Websitehttps://eksobionics.com/
Ticker SymbolEKSO
IPO dateApr 10, 2013
CEOMr. Scott G. Davis
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
449.16K
+23.08%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+166.00%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
--
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
14.90K
+54.55%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
10.58K
+53.05%
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--
Mr. Scott G. Davis
Mr. Scott G. Davis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Corinna E. Lathan
Dr. Corinna E. Lathan
Independent Director
Independent Director
--
--
,
,
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
449.16K
+23.08%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+166.00%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
--
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
14.90K
+54.55%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
10.58K
+53.05%
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
United States
1.78M
52.83%
APAC
491.00K
14.55%
France
422.00K
12.50%
Italy
407.00K
12.06%
Other EMEA
255.00K
7.56%
Other Americas
17.00K
0.50%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, Jul 25
Updated: Fri, Jul 25
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Armistice Capital LLC
5.21%
The Vanguard Group, Inc.
1.52%
Li (Kecheng)
1.18%
Lathan (Corinna)
0.98%
Cloyd (Mary Ann)
0.97%
Other
90.15%
Shareholders
Shareholders
Proportion
Armistice Capital LLC
5.21%
The Vanguard Group, Inc.
1.52%
Li (Kecheng)
1.18%
Lathan (Corinna)
0.98%
Cloyd (Mary Ann)
0.97%
Other
90.15%
Shareholder Types
Shareholders
Proportion
Hedge Fund
5.97%
Individual Investor
5.93%
Investment Advisor
1.85%
Investment Advisor/Hedge Fund
1.75%
Family Office
0.61%
Research Firm
0.07%
Other
83.83%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
69
406.27K
15.56%
+37.52K
2025Q1
74
593.71K
19.55%
+56.61K
2024Q4
73
6.22M
25.06%
-1.22M
2024Q3
72
7.69M
35.95%
+2.06M
2024Q2
75
4.32M
22.05%
+86.91K
2024Q1
79
3.58M
21.92%
+291.20K
2023Q4
84
3.20M
21.39%
-96.00K
2023Q3
87
3.97M
27.62%
+342.40K
2023Q2
88
4.47M
31.89%
+476.23K
2023Q1
90
3.34M
25.52%
-152.01K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Armistice Capital LLC
136.16K
5.79%
+21.12K
+18.35%
Mar 31, 2025
The Vanguard Group, Inc.
39.58K
1.68%
-51.00
-0.13%
Mar 31, 2025
Li (Kecheng)
30.73K
1.31%
+15.75K
+105.11%
May 16, 2025
Lathan (Corinna)
25.61K
1.09%
+15.75K
+159.61%
May 16, 2025
Cloyd (Mary Ann)
25.23K
1.07%
+15.75K
+166.00%
May 16, 2025
Davis (Scott Gerald)
22.27K
0.95%
+7.04K
+46.23%
Mar 18, 2025
Cresset Asset Management, LLC
17.96K
0.76%
-2.04K
-10.17%
Mar 31, 2025
Scher (Deborah Lafer)
15.75K
0.67%
+15.75K
--
May 16, 2025
Jones (Jason C)
14.90K
0.63%
+5.26K
+54.55%
Mar 18, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Date
Type
Ratio
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
Mar 24, 2020
Merger
15<1
KeyAI